Skip to content
Company Overview
About Bachem
Vision and Strategy
History
Sustainability
Innovation
News & Media
News
Media Library
Events
Investor Hub
Investor Hub
Reports & Presentations
Financial Events
Careers
Peptides
Clinical Development
Peptide NCE Development
Research
Custom Synthesis
Catalog Peptides
Commercial Manufacturing
Peptide API
Amino Acid Derivatives
Cosmetic Peptides
Peptides for Medical Devices
Services & Capabilities
Project Management
Quality and Regulatory
Analytical Capabilities
Supply and Vertical Integration
Oligonucleotides
Clinical Development
Oligonucleotide NCEs
Commercial Manufacturing
Oligonucleotide API
Services & Capabilities
Project Management
Quality and Regulatory
Analytical Capabilities
Supply and Vertical Integration
Locations
Bachem Worldwide
Bubendorf (CH)
Vionnaz (CH)
Torrance (US)
Vista (US)
St. Helens (UK)
Sisslerfeld (CH)
Knowledge Hub
Contact
Peptides
Back
Clinical Development
Peptide NCE Development
Research
Custom Synthesis
Catalog Peptides
Commercial Manufacturing
Peptide API
Amino Acid Derivatives
Cosmetic Peptides
Peptides for Medical Devices
Services & Capabilities
Project Management
Quality and Regulatory
Analytical Capabilities
Supply and Vertical Integration
Oligonucleotides
Back
Clinical Development
Oligonucleotide NCEs
Commercial Manufacturing
Oligonucleotide API
Services & Capabilities
Project Management
Quality and Regulatory
Analytical Capabilities
Supply and Vertical Integration
Locations
Back
Bachem Worldwide
Bubendorf (CH)
Vionnaz (CH)
Torrance (US)
Vista (US)
St. Helens (UK)
Sisslerfeld (CH)
Knowledge Hub
Contact
Company Overview
Back
About Bachem
Vision and Strategy
History
Sustainability
Innovation
News & Media
Back
News
Media Library
Events
Investor Hub
Back
Investor Hub
Reports & Presentations
Financial Events
Careers
Author:
Camilla Schäublin
30 July 2026
Bachem confirms growth and expects a strong second half 2026
Ad hoc announcement pursuant to Art. 53 LR of the Swiss stock exchange SIX
21 July 2026
Bachem plans to build a large-scale production facility in Sisslerfeld
Ad hoc announcement pursuant to Art. 53 LR of the Swiss stock exchange SIX
